news
Alternative immunotherapies improve relapsed myeloma survival
Alternative CAR-T and cell therapies increased relapsed multiple myeloma patient survival by 18 months after failed CAR-T, a study found.
List view / Grid view
Mount Sinai
news
Personalised cancer vaccine safe and potentially beneficial to patients
Mount Sinai researchers reveal that, in a Phase I trial, their personalised cancer vaccines targeting cancer neoantigens showed some early signs of potential benefit.
news
Study shows anticoagulation therapy beneficial for COVID-19 patients
Researchers have demonstrated that all regimens of anticoagulants were far superior to no anticoagulants in COVID-19 patients.
news
Sildenafil could be linked to irreversible colour vision damage
Retinal damage and long term vision problems have been identified in a patient who took a dose of slidenafil citrate over the recommended limit...
news
Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer
Researchers have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumours have certain genetic mutations...
